New business and science behind nanotech biosensors to detect viruses and bacteria attract deep tech investors and researchers.

Santa Clara, CA, October 13, 2020, / Press Release/ -
New business and science behind nanotech biosensors to detect viruses and bacteria attract deep tech investors and researchers.

Ariviya hosted an online event on the new business and science behind nanotech biosensors. Deep tech investors see the unprecedented market opportunity and scientific researchers appreciate the Nanotechnology behind the biosensor.

Nano biosensor is a technology that detects viruses and bacteria with high sensitivity and selectivity using nano-sized noble metals like Gold, Silver, Palladium, and Platinum.

The nano biosensor has a biological recognition unit and transducer that interact with antibodies and enzymes and change the bio-elemental properties into surface plasma resonance signal, says Dr. Sivakumar, Chief Technology Officer of Ariviya Inc.

Swami, CEO of Ariviya, Inc, said, the Infectious disease diagnostics market size is 23 Billion USD, with a 7.5% CAGR by 2027. The key growth drivers are increased infectious diseases' incidences globally and growing awareness of early detection. But the impact of COVID-19 in our lifestyle is hyper-accelerating these growth drivers.

In this COVID-19 era, the rising awareness about self-monitoring & diagnosis and the rapid advancement in the detection technology fuels the global home/self-diagnostics market. People perform these tests at non-healthcare places like home and workplaces to quickly identify medical conditions, cost-effectively, and repeatedly. Read that "repeatedly" as a vast and continuous market, like FMCG.

Ariviya being a "deep technology startup" founded on real science and technology innovations with strong R&D in Nanotechnology and Biotechnology, attracts investors to invest in its nanotech biosensor research and product development to meet these new huge needs.

About Ariviya Inc.
Ariviya is a Nano biotech Startup from the heart of Silicon Valley at Santa Clara, California, with an R&PD center in India, invents scientific, scalable, marketable solutions for real-world problems in human wellness & animal welfare. At Ariviya, we apply Lean methodology and Deep Technologies from Nanotechnology, Biotechnology, Polymer Technology in research and product development, and commercialization. Ariviya's technology pipelines are deep science-based and balanced to de-risk investments. They consist of Nano Biosensors Technology, Natural Antimicrobial Polymer Technology, Wound Care & Burn Management Technology, and Natural Udder Care Technology.

For more information about the company, please visit www.ariviya.com.
Contact Us
Ariviya, Inc.
BioCurious.
3108 Patrick Henry Dr,
Santa Clara, CA, 95054, United States
info@ariviya.com
+1 (650) 704-9343

825 Maria Ln, Sunnyvale, CA 94087, United States

Ariviya is a Nano biotech Startup from the heart of Silicon Valley at Santa Clara, California, with an R&PD center in India, invents scientific, scalable, marketable solutions for real-world problems in human wellness & animal welfare. At Ariviya, we apply Lean methodology and Deep Technologies from Nanotechnology, Biotechnology, Polymer Technology in research and product development, and commercialization. Ariviya's technology pipelines are deep science-based and balanced to de-risk investments. They consist of Nano Biosensors Technology, Natural Antimicrobial Polymer Technology, Wound Care & Burn Management Technology, and Natural Udder Care Technology.

This release was published on openPR.